Structure-based design, synthesis and biological evaluation of new N-carboxyphenylpyrrole derivatives as HIV fusion inhibitors targeting gp41.
about
Identification of fragments targeting an alternative pocket on HIV-1 gp41 by NMR screening and similarity searching.Design and characterization of swapped-domain constructs of HIV-1 glycoprotein-41 as receptors for drug discovery.Enhanced potency of bivalent small molecule gp41 inhibitors.Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor designIdentification and characterization of inhibitors of the aminoglycoside resistance acetyltransferase Eis from Mycobacterium tuberculosisDevelopment of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41HIV microbicides: state-of-the-art and new perspectives on the development of entry inhibitors.De novo design: balancing novelty and confined chemical space.Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocketSynthesis, Biological Evaluation and Molecular Docking Studies of Novel 4-Arylpyridin-1(4H)-yl) benzoic acid Derivatives as Anti-HIV-1 Agents.Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015).Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 glycoprotein-41.An effective conjugation strategy for designing short peptide-based HIV-1 fusion inhibitors.Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket
P2860
Q30660631-154A755B-04FA-4CB5-9044-3A825CB14A91Q30912819-8CA6EA6F-9247-499A-9989-D5E6AF61460EQ34546445-F5FCBC88-0642-47DA-92EF-83C830288A3BQ35563298-2591B7CB-2065-48CF-A4DB-6FA0F6E15BFDQ36107474-3C6655B5-BB38-482F-9220-520EEE6BC364Q36643050-CFB1E575-06BE-4D2B-8956-B221570E2171Q37855900-A4AC1504-F7BB-4C3C-B24E-CCD6B455D664Q38029143-0F04B763-9E82-4A7D-8099-72198A083C36Q38076321-848E9A34-1C1F-4E1C-AD91-F6608EA612EFQ38694321-D238CBB5-E6DE-4A6A-A124-29A896813ACDQ39026832-F53E13C4-18EA-4D68-8A15-CB4B7D9A7D79Q39079796-1E30360F-E9B0-4E0A-AC29-C54D582CF645Q39471914-A53DEB63-20DB-460D-A624-1939B9C3D003Q42050970-9446FB66-9CFE-4496-939D-822666BEFBD7Q42701017-B16194DF-C658-445F-A558-7B5E8ED6125B
P2860
Structure-based design, synthesis and biological evaluation of new N-carboxyphenylpyrrole derivatives as HIV fusion inhibitors targeting gp41.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Structure-based design, synthe ...... ion inhibitors targeting gp41.
@ast
Structure-based design, synthe ...... ion inhibitors targeting gp41.
@en
type
label
Structure-based design, synthe ...... ion inhibitors targeting gp41.
@ast
Structure-based design, synthe ...... ion inhibitors targeting gp41.
@en
prefLabel
Structure-based design, synthe ...... ion inhibitors targeting gp41.
@ast
Structure-based design, synthe ...... ion inhibitors targeting gp41.
@en
P2093
P2860
P1476
Structure-based design, synthe ...... ion inhibitors targeting gp41.
@en
P2093
P2860
P304
P356
10.1016/J.BMCL.2009.10.139
P407
P50
P577
2009-11-05T00:00:00Z